Modification of the antigenicity of cancer cells by conjugates consisting of hyaluronic acid and foreign antigens
Biomaterials Science · 2023
DOI: 10.1039/d3bm00439b ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2023. Verfasst von Soichi Ogata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Kitakyushu, 1-1 Hibikino, Wakamatsu-ku, Kitakyushu, Fukuoka 808-0135, Japan. mochizuki@ki…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Hyaluronic acid (HA) delivers conjugated foreign antigens to cancer cells, resulting in changing the presenting antigens on MHC class I molecules from self-antigens to foreign antigens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The University of Kitakyushu, 1-1 Hibikino, Wakamatsu-ku, Kitakyushu, Fukuoka 808-0135, Japan. mochizuki@kitakyu-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ogata, S., Tsuji, R., Moritaka, A., Ito, S., & Mochizuki, S. (2023). Modification of the antigenicity of cancer cells by conjugates consisting of hyaluronic acid and foreign antigens. Biomaterials Science. https://doi.org/10.1039/d3bm00439b
Vancouver
Ogata S, Tsuji R, Moritaka A, Ito S, Mochizuki S. Modification of the antigenicity of cancer cells by conjugates consisting of hyaluronic acid and foreign antigens. Biomaterials Science. 2023. doi:10.1039/d3bm00439b
BibTeX
@article{Ogata2023,
author = {Ogata, Soichi and Tsuji, Reika and Moritaka, Atsushi and Ito, Shoya and Mochizuki, Shinichi},
title = {Modification of the antigenicity of cancer cells by conjugates consisting of hyaluronic acid and foreign antigens},
journal = {Biomaterials Science},
year = {2023},
doi = {10.1039/d3bm00439b}
}
EUVIMED